Highlights
IIA supported (ever)1 patent
About
Transcatheter Treatment for Valve Insufficiency
Cuspa is developing an artificial cusp for use in treating aortic valve insufficiency (AI), a heart disorder in which the valve does not close properly and allows blood to flow backward into the heart. The companys CUSPER is an artificial cusp, connected to a grasper, that is attached to the native valve cusp/leaflet for the treatment of AI.
Cusper is attached to the native aortic valve cusp using a nitinol grasper, it preserves the functionality of an healthy aortic and prevents valve insuffiency. After demonstrating proof of concept, Cuspa Medical is carrying out pre-clinical studies on pigs, with the objective to optimize Cusper‘s performance.
Identity
| Name | Cuspa |
|---|---|
| Slug | cuspa |
| Type / kind | startup |
| Crunchbase ID | cuspa-ltd |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4I6isYsKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Nazareth |
| HQ address | Wadi el-Haj Street 13, Nazareth, Israel |
Web & social
| Website | https://cuspamedical.com |
|---|---|
| https://www.linkedin.com/company/82134919 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
heart-diseasesminimally-invasivecardiologycardiovascularvalvesmedical-devicescatheters
Funding
| Total raised | $900K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}